R

Respiri Ltd
ASX:RSH

Watchlist Manager
Respiri Ltd
ASX:RSH
Watchlist
Price: 0.08 AUD Market Closed
Market Cap: 103.3m AUD
Have any thoughts about
Respiri Ltd?
Write Note

Intrinsic Value

The intrinsic value of one RSH stock under the Base Case scenario is 0.01 AUD. Compared to the current market price of 0.08 AUD, Respiri Ltd is Overvalued by 90%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RSH Intrinsic Value
0.01 AUD
Overvaluation 90%
Intrinsic Value
Price
R
Worst Case
Base Case
Best Case

Valuation Backtest
Respiri Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for RSH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about RSH?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Respiri Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Respiri Ltd

Provide an overview of the primary business activities
of Respiri Ltd.

What unique competitive advantages
does Respiri Ltd hold over its rivals?

What risks and challenges
does Respiri Ltd face in the near future?

Has there been any significant insider trading activity
in Respiri Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Respiri Ltd.

Provide P/S
for Respiri Ltd.

Provide P/E
for Respiri Ltd.

Provide P/OCF
for Respiri Ltd.

Provide P/FCFE
for Respiri Ltd.

Provide P/B
for Respiri Ltd.

Provide EV/S
for Respiri Ltd.

Provide EV/GP
for Respiri Ltd.

Provide EV/EBITDA
for Respiri Ltd.

Provide EV/EBIT
for Respiri Ltd.

Provide EV/OCF
for Respiri Ltd.

Provide EV/FCFF
for Respiri Ltd.

Provide EV/IC
for Respiri Ltd.

What are the Revenue projections
for Respiri Ltd?

How accurate were the past Revenue estimates
for Respiri Ltd?

What are the Net Income projections
for Respiri Ltd?

How accurate were the past Net Income estimates
for Respiri Ltd?

What are the EPS projections
for Respiri Ltd?

How accurate were the past EPS estimates
for Respiri Ltd?

What are the EBIT projections
for Respiri Ltd?

How accurate were the past EBIT estimates
for Respiri Ltd?

Compare the revenue forecasts
for Respiri Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Respiri Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Respiri Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Respiri Ltd compared to its peers.

Compare the P/E ratios
of Respiri Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Respiri Ltd with its peers.

Analyze the financial leverage
of Respiri Ltd compared to its main competitors.

Show all profitability ratios
for Respiri Ltd.

Provide ROE
for Respiri Ltd.

Provide ROA
for Respiri Ltd.

Provide ROIC
for Respiri Ltd.

Provide ROCE
for Respiri Ltd.

Provide Gross Margin
for Respiri Ltd.

Provide Operating Margin
for Respiri Ltd.

Provide Net Margin
for Respiri Ltd.

Provide FCF Margin
for Respiri Ltd.

Show all solvency ratios
for Respiri Ltd.

Provide D/E Ratio
for Respiri Ltd.

Provide D/A Ratio
for Respiri Ltd.

Provide Interest Coverage Ratio
for Respiri Ltd.

Provide Altman Z-Score Ratio
for Respiri Ltd.

Provide Quick Ratio
for Respiri Ltd.

Provide Current Ratio
for Respiri Ltd.

Provide Cash Ratio
for Respiri Ltd.

What is the historical Revenue growth
over the last 5 years for Respiri Ltd?

What is the historical Net Income growth
over the last 5 years for Respiri Ltd?

What is the current Free Cash Flow
of Respiri Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Respiri Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Respiri Ltd

Current Assets 4m
Cash & Short-Term Investments 762.9k
Receivables 253.1k
Other Current Assets 3m
Non-Current Assets 2.2m
PP&E 117k
Intangibles 2m
Current Liabilities 3.4m
Accounts Payable 1.9m
Accrued Liabilities 201.4k
Other Current Liabilities 1.3m
Non-Current Liabilities 127.9k
Long-Term Debt 57.4k
Other Non-Current Liabilities 70.5k
Efficiency

Earnings Waterfall
Respiri Ltd

Revenue
1m AUD
Operating Expenses
-8.1m AUD
Operating Income
-7.1m AUD
Other Expenses
-74.8k AUD
Net Income
-7.1m AUD

Free Cash Flow Analysis
Respiri Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

RSH Profitability Score
Profitability Due Diligence

Respiri Ltd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional 1-Year Revenue Growth
Negative 3-Years Revenue Growth
Declining ROE
29/100
Profitability
Score

Respiri Ltd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

RSH Solvency Score
Solvency Due Diligence

Respiri Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
55/100
Solvency
Score

Respiri Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RSH Price Targets Summary
Respiri Ltd

There are no price targets for RSH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for RSH?

Click here to dive deeper.

Dividends

Respiri Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for RSH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

RSH Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Respiri Ltd

Country

Australia

Industry

Health Care

Market Cap

103.3m AUD

Dividend Yield

0%

Description

Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-07-14. The firm's segments include Australia and Israel. The Australia segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment is engaged in research, development and commercialization of medical devices, and the production of mobile health applications in Israel. The firm has developed a wheezo, which is an eHealth Saas platform that uses a device and app to measure, record and assist asthma monitoring. Its device and app make up a cloud-based mobile health platform that records wheeze and other clinically relevant symptoms and signs of asthma.

Contact

VICTORIA
Melbourne
Level 9, 432 St Kilda Road
+611300117377.0
respiri.com.au

IPO

2000-07-14

Employees

-

Officers

Executive Chairman
Mr. Nicholas Smedley
CEO, MD & Executive Director
Mr. Marjan Mikel B.Sc., M.A.I.C.D.
Chief Operations Officer
Mr. Peter Hildebrandt
Chief Technology Officer
Mr. George Vlachodimitropoulos
Chief Research Officer
Dr. Samaneh Sarraf Shirazi
Chief Commercial Officer
Mr. Theo Antonopoulos
Show More
Head of US Operations & Chief Commercial Officer for the US market
Mr. William Sigsbee
Joint Company Secretary
Ms. Nova Anne Taylor
Medical & Scientific Advisor
Prof. Noam Gavriely
Show Less

See Also

Discover More
What is the Intrinsic Value of one RSH stock?

The intrinsic value of one RSH stock under the Base Case scenario is 0.01 AUD.

Is RSH stock undervalued or overvalued?

Compared to the current market price of 0.08 AUD, Respiri Ltd is Overvalued by 90%.

Back to Top